Novo Nordisk Sues Eli Lilly Over Weight Loss Drug Advertisement
Novo Dordisk, which makes Ozempic and Wegovy, has filed a federal lawsuit against Eli Lilly, accusing its competitor of false advertising and unfair competition. Novo Nordisk challenges national ad campaigns from Eli Lilly that compare GLP-1 drugs from both companies, saying that Lilly intentionally relies on outdated clinical trials to paint a false and misleading picture. NBC’s Christine Romans joins TODAY with the details.
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)